The Phase I Single-center, Single-blind, Randomized Clinical Study of the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of Injectable SPN01
Latest Information Update: 05 Dec 2024
Price :
$35 *
At a glance
- Drugs SPN 01 (Primary)
- Indications Colorectal cancer
- Focus Adverse reactions
- Sponsors Beijing SonoPhotoNano Medical Technology
- 05 Dec 2024 New trial record